December 11, 2019
The company submitted a new drug application to the US Food and Drug Administration for its treatment IV tramadol.
July 4, 2019
We're halfway through the year, which means it's time to reflect on the top performing NASDAQ pharma stocks year-to-date.
June 9, 2019
INN looks at the top NASDAQ biotech and pharma stocks over the course of the week and what may have...
December 19, 2018
Avenue Therapeutics (NASDAQ:ATXI) a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today announced that...
November 18, 2018
Cocrystal Pharma, Ra Pharmaceuticals, Avenue Therapeutics, Imprimis Pharmaceuticals and Nightstar Therapeutics were last week's top gainers on the NASDAQ Biotechnology...